Abdominal diseases in children
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Under 18 years old, above 1 year old, height 74cm or above. 2. Abdominal surgery is required, including but not limited to radical choledochal cyst resection, cholecystectomy, splenectomy, abdominal mass resection, enterectomy enterostomy, appendectomy and other pediatric surgical abdominal surgery. 3. Patients classified as Class I-III by the American Society of Anesthesiologists (ASA) Physical Status Classification system. 4. Be able to cooperate with the plan to complete the visit and related inspection. 5. The subject voluntarily participates in the clinical trial and agrees or the guardian agrees to sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients in need of emergency surgical intervention; Anaesthesia assessment of patients who cannot tolerate pneumoperitoneum 2. There is a history of other underlying diseases and the investigator considers it unsuitable for inclusion in this study. 3. Patients who had previously received other abdominal surgery and were assessed by the investigators as unfit to participate in this study. 4. HIV antibody positive; Hepatitis B surface antigen (HbsAg) positive and hepatitis B virus DNA (HBV-DNA) copy number higher than the lower limit of detection or normal range; Hepatitis C virus (HCV) antibody positive; Patients who are antibody positive for treponema pallidum and have been judged by researchers to be at greater risk of infection. 5. Patients with serious systemic diseases who are judged by researchers to be unsuitable for surgical treatment. 6. Long-term use of anticoagulant and antiplatelet drugs (antiplatelet aggregation drugs stopped less than 1 week before surgery), with a history of hemorrhagic disease or hematopoietic dysfunction or coagulation dysfunction. 7. People with severe allergies and suspected or confirmed addiction to alcohol, drugs or drugs. 8. Patients with a history of epilepsy or mental illness or cognitive impairment. 9. Those who are participating in other interventional clinical trials. 10. Other conditions that the investigator considers inappropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complication rate; | — |
Countries
China
Contacts
Guangzhou Women and Children Medical Center